Abstract
Objective
To explore compliance with statin treatment over a period of 4.5 years follow-up in an Italian population and to investigate the degree of persistence and continuity in subjects with cardiovascular diseases.
Methods
Pharmaceutical, medical and demographic data were retrieved from the database of Umbria Regional Government's Epidemiology Department. Statin users were stratified in different cohorts according to drug use, aspirin use and hospital admission for cardiovascular diseases. Compliance was considered in terms of persistence and continuity. Persistence was defined as discontinued if the delay between the end of the first period of treatment and the prescription renewal exceeded 30 days. Continuity was defined as consecutive annual renewal of prescription.
Results
Statin users (n=39,222) were identified. The median persistence on statin treatment was 5.3 months. Only 12.8% subjects were found to be persistent, while 49.6% renewed their prescription for consecutive years. The cohorts of aspirin use and major cardiovascular events were predictive of good compliance. In these cohorts subjects under 45 years showed the best rate of persistence and continuity.
Conclusion
The study reveals low compliance among subjects who presumably receive prescriptions for primary prevention. We consider it important for these groups of patients to receive greater attention and better information.
Similar content being viewed by others
References
The AFCAPS/TexCAPS Study Group (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 279:1615–1622
The West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307
The Scandinavian Simvastatin Survival Study Group (1994) Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Study (4S). Lancet 344:1383–1389
The CARE Study Group (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335:1001–1009
Le nuove note CUF (2000) Nota 13. Bollettino d'informazione sui farmaci. Anno VII N 5–6:7–9
Il consumo di statine a livello internazionale e nel contesto italiano (2001) Bollettino d'informazione sui farmaci. Anno VIII N 4–5:194–201
Larsen J, Andersen M, Kragstrup J, Gram LF (2002) High persistence of statin use in a Danish population: compliance study 1993–1998. Br J Clin Pharmacol 53:375–378
Sampietro T, Geletta F, Bionda A (1995) Behavior of Lp (a) and apoproteins (A1, B, C2, C3, E) during and after therapy with simvastatin. Cardiovasc Drugs Ther 9:785–789
Avorn J, Monette J, Lacour A, et al (1998) Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279:1458–1462
Larsen J, Vaccheri A, Andersen M, Montanaro N, Bergman U (2000) Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Br J Clin Pharmacol. 49:463–471
Simons LA, Levis G, Simons J (1996) Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust 164:208–211
Catalan V, LeLorier J (2002) Predictors of long term persistence on statins in a subsidized clinical population. Value in Health 3:417–426
Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J (2002) Long-term persistence in use of statin therapy in elderly patients. JAMA 288:455–461
Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288:462–467
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abraha, I., Montedori, A., Stracci, F. et al. Statin compliance in the Umbrian population. Eur J Clin Pharmacol 59, 659–661 (2003). https://doi.org/10.1007/s00228-003-0675-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0675-2